Literature DB >> 34671740

Influence of ring size in conformationally restricted ring I analogs of paromomycin on antiribosomal and antibacterial activity.

Michael G Pirrone1,2,3, Sven N Hobbie4, Andrea Vasella5, Erik C Böttger4, David Crich1,2,6.   

Abstract

In order to further investigate the importance of the conformation of the ring I side chain in aminoglycoside antibiotic binding to the ribosomal target several derivatives of paromomycin were designed with conformationally locked side chains. By changing the size of the appended ring between O-4' and C-6' used to restrict the motion of the side chain, the position of the C-6' hydroxy group was fine tuned to probe for the optimal conformation for inhibition of the ribosome. While the changes in orientation of the 6'-hydroxy group cannot be completely dissociated from the size and hydrophobicity of the conformation-restricting ring, overall, it is apparent that the preferred conformation of the ring I side chain for interaction with A1408 in the decoding A site of the bacterial ribosome is an ideal gt conformation, which results in the highest antimicrobial activity as well as increased selectivity for bacterial over eukaryotic ribosomes. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2021        PMID: 34671740      PMCID: PMC8459383          DOI: 10.1039/d1md00214g

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  34 in total

Review 1.  The methylation effect in medicinal chemistry.

Authors:  Eliezer J Barreiro; Arthur E Kümmerle; Carlos A M Fraga
Journal:  Chem Rev       Date:  2011-06-01       Impact factor: 60.622

2.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597

3.  Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.

Authors:  Ri-Bai Yan; Min Yuan; Yanfen Wu; Xuefu You; Xin-Shan Ye
Journal:  Bioorg Med Chem       Date:  2010-12-04       Impact factor: 3.641

4.  Thermodynamics of aminoglycoside-rRNA recognition: the binding of neomycin-class aminoglycosides to the A site of 16S rRNA.

Authors:  Malvika Kaul; Daniel S Pilch
Journal:  Biochemistry       Date:  2002-06-18       Impact factor: 3.162

5.  Differential selectivity of natural and synthetic aminoglycosides towards the eukaryotic and prokaryotic decoding A sites.

Authors:  Jiro Kondo; Mariana Hainrichson; Igor Nudelman; Dalia Shallom-Shezifi; Christopher M Barbieri; Daniel S Pilch; Eric Westhof; Timor Baasov
Journal:  Chembiochem       Date:  2007-09-24       Impact factor: 3.164

6.  The molecular basis for A-site mutations conferring aminoglycoside resistance: relationship between ribosomal susceptibility and X-ray crystal structures.

Authors:  Peter Pfister; Sven Hobbie; Quentin Vicens; Erik C Böttger; Eric Westhof
Journal:  Chembiochem       Date:  2003-10-06       Impact factor: 3.164

7.  Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin.

Authors:  Tanja Matt; Chyan Leong Ng; Kathrin Lang; Su-Hua Sha; Rashid Akbergenov; Dmitri Shcherbakov; Martin Meyer; Stefan Duscha; Jing Xie; Srinivas R Dubbaka; Déborah Perez-Fernandez; Andrea Vasella; V Ramakrishnan; Jochen Schacht; Erik C Böttger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-14       Impact factor: 11.205

8.  Predictive Analysis of the Side Chain Conformation of the Higher Carbon Sugars: Application to the Preorganization of the Aminoglycoside Ring 1 Side Chain for Binding to the Bacterial Ribosomal Decoding A Site.

Authors:  Michael G Pirrone; Marina Gysin; Klara Haldimann; Sven N Hobbie; Andrea Vasella; David Crich
Journal:  J Org Chem       Date:  2020-09-23       Impact factor: 4.354

9.  Identification and evaluation of improved 4'-O-(alkyl) 4,5-disubstituted 2-deoxystreptamines as next-generation aminoglycoside antibiotics.

Authors:  Stefan Duscha; Heithem Boukari; Dimitri Shcherbakov; Sumantha Salian; Sandrina Silva; Ann Kendall; Takayuki Kato; Rashid Akbergenov; Deborah Perez-Fernandez; Bruno Bernet; Swapna Vaddi; Pia Thommes; Jochen Schacht; David Crich; Andrea Vasella; Erik C Böttger
Journal:  MBio       Date:  2014-09-30       Impact factor: 7.867

10.  An Advanced Apralog with Increased in vitro and in vivo Activity toward Gram-negative Pathogens and Reduced ex vivo Cochleotoxicity.

Authors:  Amr Sonousi; Jonathan C K Quirke; Prabuddha Waduge; Tanja Janusic; Marina Gysin; Klara Haldimann; Shan Xu; Sven N Hobbie; Su-Hua Sha; Jochen Schacht; Christine S Chow; Andrea Vasella; Erik C Böttger; David Crich
Journal:  ChemMedChem       Date:  2020-10-23       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.